It’s been one year since the first case of COVID-19 was detected in the United States, and still Feinberg investigators continue to investigate the disease, its evolution and its impact on society.
Northwestern Medicine investigators have discovered that inhibiting tumor-associated myeloid cells ability to produce specialized metabolites called polyamines may improve the effectiveness of treatments for glioblastoma.
Since March 2020, a team of Northwestern Medicine scientists have been tracking the evolution of SARS- CoV-2, specifically in the city of Chicago. Their work has been pivotal in understanding how the virus spread to Chicago and what new variants have emerged in the city.
Forty-four new members were inducted into Northwestern’s chapter of the Alpha Omega Alpha medical honor society during a virtual ceremony on March 17.
Feinberg’s Department of Pharmacology has expanded in size, faculty, and research focus, and is looking ahead to future growth in the field.
Linda Suleiman, MD, ’17 GME, and Quentin Youmans, ’15 MD, ’18 GME, have been included in the National Minority Quality Forum’s 2021 “40 Under 40 Leaders in Minority Health” list.
Endoscopic submucosal dissection can be performed as safely and effectively as alternative techniques and is associated with lower cancer recurrence, according to a recent study.
Northwestern Medicine investigators discovered that nuclear surface proteins called nuclear lamin isoforms regulate nuclear pore complexes, shedding light on the role molecular mechanisms play in genetic mutations behind many rare diseases.
Second-year medical student Tricia Pendergrast has been included in Crain’s Chicago Business 2021 Notable Healthcare Heroes list for co-founding and operating GetMePPEChicago.
A team of Northwestern Medicine scientists have discovered that a specific type of immune cell is necessary for the suppression of chronic inflammation, revealing a potential therapeutic target for patients with rheumatoid arthritis.